ArticlePharmacogenomics and personalized medicine2026
Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study.
Ruixue Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.